menu search

Thanks to these crispr stocks, the path to rewriting human dna is about to get pretty fierce

Experts say CRISPR-based treatments could soon constitute a massive market — and the prospects are gr...

March 24, 2022, 6:19 pm

Why is biondvax (bvxv) stock up today?

BVXV stock is climbing today on news that BiondVax has struck a deal to pursue a range of antibody treatments<...

March 24, 2022, 1:15 pm

Irwin naturals announces strategy to add new mental health treatments and collaborate with third-party payors

Irwin Naturals Inc. (CSE:IWIN) has announced its planned suite of clinic services for its chain of psychedelic mental health clinics—Irwin Naturals ...

March 24, 2022, 8:49 am

Context therapeutics closes 2021 with balance sheet of nearly $50m

Context Therapeutics Inc said it closed 2021 with a balance sheet of nearly $50 million. As of December 31, 2021, the women's oncology company develo...

March 23, 2022, 4:34 pm

Decibel therapeutics to participate in upcoming investor conferences

BOSTON, March 22, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and de...

March 22, 2022, 7:30 am

Pfizer to supply 4 million covid antiviral treatments to poorer nations through unicef

Pfizer expects to start starting supplying the antiviral pills, Paxlovid, to UNICEF starting next month and will continue to do so through the end of ...

March 22, 2022, 6:45 am

Wellbeing digital sciences sees 2q revenue of c$1.7m in first reporting period as it continues to grow mental wellness treatment clinics

Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) Inc announced second-quarter 2022 revenue of C$1,660,158, as the firm said it has transitioned ...

March 18, 2022, 9:20 am

Abbvie (abbv) inks deal for neuropsychiatric conditions

AbbVie (ABBV) forges an alliance with Gedeon Richter to develop novel treatments for neuropsychiatric d...

March 14, 2022, 12:02 pm

Pfizer closes $6.7 billion acquisition of arena pharmaceuticals

Shares of Pfizer Inc. PFE, +2.32% were up 2.0% in trading on Friday after the company said it closed its $6.7 billion acquisition of Arena Pharmaceuti...

March 11, 2022, 11:04 am

Wednesdays with wedbush: 3 smid-cap biotech stock picks

Since the coronavirus pandemic began in early 2020, the FDA's plate has been full with reviews of COVID-19 vaccines and ...

March 9, 2022, 12:03 pm

Diamedica therapeutics to report fourth quarter 2021 financial results and provide a business update march 15, 2022

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel ...

March 8, 2022, 8:13 am

Is a rise imminent for intellia therapeutics stock after 30% fall in a month?

The stock price of Intellia Therapeutics, a biotechnology company developing treatments using a CRISPR ...

March 8, 2022, 6:30 am

Health care stocks to watch as test to treat plan looks to prevent lockdowns

President Joe Biden announced during his State of the Union address on Tuesday that individuals who test positive for Covid-19 at a pharmacy will soon...

March 3, 2022, 4:29 pm

Health care stocks to watch as test to treat plan looks to prevent lockdowns

President Joe Biden announced during his State of the Union address on Tuesday that individuals who test positive for Covid-19 at a pharmacy will soon...

March 3, 2022, 4:29 pm

Health care stocks to watch as test to treat plan looks to prevent lockdowns

President Joe Biden announced during his State of the Union address on Tuesday that individuals who test positive for Covid-19 at a pharmacy will soon...

March 3, 2022, 4:29 pm

Viridian therapeutics to report fourth quarter and full year 2021 financial results and host investor conference call on march 10, 2022

WALTHAM, Mass., March 03, 2022 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company advancing new ...

March 3, 2022, 4:16 pm

Viridian therapeutics to report fourth quarter and full year 2021 financial results and host investor conference call on march 10, 2022

WALTHAM, Mass., March 03, 2022 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company advancing new ...

March 3, 2022, 4:16 pm

Viridian therapeutics to report fourth quarter and full year 2021 financial results and host investor conference call on march 10, 2022

WALTHAM, Mass., March 03, 2022 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company advancing new ...

March 3, 2022, 4:16 pm

Alpine immune sciences announces participation in march investor conferences

SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative...

March 1, 2022, 8:05 am

Alpine immune sciences announces participation in march investor conferences

SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative...

March 1, 2022, 8:05 am


Search within

Pages Search Results: